New drug shows promise for recurrent ovarian cancer in phase 2 trial
NCT ID NCT05041257
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 23 times
Summary
This phase 2 study tested a drug called mirvetuximab soravtansine in 79 people with recurrent ovarian, peritoneal, or fallopian tube cancer that had high levels of a protein called folate receptor-alpha. The cancer had come back after platinum-based chemotherapy but was still sensitive to it. The main goal was to see how many participants had their tumors shrink or disappear. The study is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bon Secours Cork Hospital /ID# 269851
Cork, T12 DV56, Ireland
-
Centre Armoricain de Radiotherapie Imagerie & Oncologie (CARIO) /ID# 269847
Plérin, Cotes-d Armor, 22190, France
-
Centre Leon Berard /ID# 269848
Lyon, Rhone, 69373, France
-
City of Hope National Medical Center /ID# 269928
Duarte, California, 91010, United States
-
Cleveland Clinic Main Campus /ID# 269922
Cleveland, Ohio, 44195, United States
-
Duplicate_SCRI - Tennessee Oncology /ID# 269921
Nashville, Tennessee, 37203-1632, United States
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 269861
Rome, Roma, 00168, Italy
-
Holy Name Medical Center /ID# 269927
Teaneck, New Jersey, 07666, United States
-
Hospital Clínico Universitario de Valencia /ID# 269893
Valencia, 46010, Spain
-
Hospital MD Anderson Cancer Center Madrid /ID# 269888
Madrid, 28033, Spain
-
Hospital Universitario HM Sanchinarro /ID# 269891
Madrid, 28050, Spain
-
Hospital Universitario La Paz /ID# 269890
Madrid, 28046, Spain
-
Hospital Universitario Reina Sofia /ID# 269892
Córdoba, Cordoba, 14004, Spain
-
Hospital Universitario Vall d'Hebron /ID# 269889
Barcelona, 08035, Spain
-
Hospital Universitario Virgen del Rocio /ID# 269894
Seville, 41013, Spain
-
Hospital Universitario de Jaén /ID# 269895
Jaén, Jaen, 23007, Spain
-
IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 269862
Bologna, 40138, Italy
-
Institut de Cancérologie de l'Ouest René Gauducheau /ID# 269846
Saint-Herblain, Loire-Atlantique, 44805, France
-
Institut de cancérologie Strasbourg Europe (ICANS) /ID# 269849
Strasbourg, 67200, France
-
Istituto Europeo Di Oncologia /ID# 269860
Milan, Milano, 20141, Italy
-
Istituto Nazionale Dei Tumori /ID# 269864
Milan, Milano, 20133, Italy
-
Istituto Nazionale Tumori Irccs Fondazione G. Pascale /ID# 269863
Naples, Napoli, 80131, Italy
-
Monash Health - Monash Medical Centre /ID# 269735
Clayton, Victoria, 3168, Australia
-
Newcastle Private Hosptial /ID# 269734
Lambton Heights, New South Wales, 2305, Australia
-
Texas Oncology - South Austin /ID# 269924
Austin, Texas, 78745, United States
-
The Mark H Zangmeister Center /ID# 269929
Columbus, Ohio, 43219, United States
-
UCL Namur University Hospital, Site Sainte-Elisabeth /ID# 269738
Namur, 5000, Belgium
-
UZ Gent /ID# 269737
Ghent, Oost-Vlaanderen, 9000, Belgium
-
Universitair Ziekenhuis Leuven /ID# 269736
Leuven, Vlaams-Brabant, 3000, Belgium
-
University Colorado Cancer Center /ID# 269930
Aurora, Colorado, 80045-2517, United States
-
University of California Los Angeles /ID# 269969
Los Angeles, California, 90095-3075, United States
-
Virginia Oncology Associates - Norfolk (Lake Wright) /ID# 269926
Norfolk, Virginia, 23502, United States
-
Waterford Regional Hospital /ID# 269852
Waterford, X91 ER8E, Ireland
-
Women & Infants Hospital /ID# 269923
Providence, Rhode Island, 02905, United States
-
Women'S Cancer Care /ID# 269925
Covington, Louisiana, 70433, United States
Conditions
Explore the condition pages connected to this study.